Logo Image
|Webcasts|October 10, 2019

GrantPlan: Create Grant Budgets with Confidence and Accuracy

By using GrantPlan, the industry’s largest investigator grant database, teams can narrow down their budget inputs by choosing procedures that precisely match the protocol. They can also choose the exact rare disease indication. GrantPlan. Make precise decisions that are based on robust data and advanced analytics. Live: Thursday, Oct. 10, 2019 at 11am EDT On demand available after airing until Oct. 10, 2020. Register free: Register free

Register free:  http://www.appliedclinicaltrialsonline.com/act_w/grantplan

Event Overview:

The complexities of modern trials offer little room for error. Intricate protocols are often coupled with large enrollment requirements, global site networks, shortened timelines and the always added pressure to deliver better results at lower costs. 

GrantPlan helps mitigate the pressure:

  • Drive Compliance

  • Ensure FMV

  • Eliminate Time-Consuming Searches

  • Eradicate Uncertainty

…allowing your team to accurately budget and negotiate trials with confidence.

Key Learning Objectives:

IQVIA Technologies’ GrantPlan is the industry’s most comprehensive and accurate benchmarking tool, enabling organizations to confidently forecast, budget, and negotiate investigator grant costs electronically.

GrantPlan is accurate because it employs more data than any other industry tool available providing accurate FMV costs.

Speakers: Mike Jozefowicz, Associate Director, IQVIA Technologies

Alex McSherry, Associate Director, IQVIA Technologies

Time and date: Thursday, Oct. 10, 2019 at 11am EDT

On demand available after airing until Oct. 10, 2020.

Sponsor: IQVIA Technologies

Register free:  http://www.appliedclinicaltrialsonline.com/act_w/grantplan

Related to this article

View more
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
The Human Side of Clinical Trials: How Measuring Readiness at Training Predicts Trial Risk Before It Shows Up in the Data
This episode of The Human Side of Clinical Trials, hosted by Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., explores why training completion metrics like attendance and quiz scores fail to capture true study readiness, and how measuring both competence and confidence can reveal trial risks before enrollment even begins.
Read more
What the Epilepsy Community Has Taught Us About Trial Feasibility
What the Epilepsy Community Has Taught Us About Trial Feasibility
In this video interview, Amélie Lothe, global medical community head for rare epilepsies at UCB Pharma, shares what she has learned firsthand from families living with Dravet syndrome and CDKL5 deficiency disorder about what makes trial participation possible—and what makes it not.
Read more